LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Strona główna・Stock List・Intellia Therapeutics Inc

Search

Intellia Therapeutics Inc

Open

Sector Healthcare

15.19 3.05

Overview

Share price change

24h

Current

Min

14.58

Max

15.28

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+297.57 upside

Dividends
By Dow Jones
Next Earnings	7 lis 2024

News Sentiment

By Acuity

50%

50%

167 / 390 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

13.95 / 21.0929 Support & Resistance

Intellia Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 wrz 2024, 17:01 UTC

Top News

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update

12 wrz 2024, 11:00 UTC

Top News

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ

8 sty 2024, 12:52 UTC

Market Talk

Regeneron's 4Q Eylea Sales Look a Bit Light -- Market Talk

24 lis 2023, 12:00 UTC

Top News

Gene Editing Will Change Medicine -- and Maybe Health Investing Too -- Heard on the Street -- WSJ

Peer Comparison

Price change

Intellia Therapeutics Inc Forecast

Price Target

By TipRanks

297.57% upside

12 Months Forecast

Average 58.88 USD 297.57%

High 95 USD

Low 18 USD

Based on 20 Wall Street analysts offering 12 month price targets forIntellia Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

20 ratings

16

Buy

4

Hold

0

Sell

Based on 20 analysts giving stock ratings to Intellia Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

13.95 / 21.0929Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

All events are bearish.

Sentiment

By Acuity

167 / 390 Ranking in Healthcare

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

805.71

UNH

UnitedHealth Group Inc

556.95

JNJ

Johnson and Johnson

158.12

NVO

Novo Nordisk A-S

109.92

ABBV

AbbVie Inc

200.71